INGERRAND.NSINGERRAND.NSNSE
Loading
Ingersoll-Rand (India) Limited manufactures and distributes air compressors, air treatment equipment, and power tools across India and export markets. The company operates as a subsidiary of Ingersoll Rand Inc., leveraging global technology with local manufacturing capabilities in Naroda (Gujarat) and Bengaluru facilities. With 43.9% gross margins and minimal debt (0.02 D/E), the company benefits from India's industrial capex cycle, infrastructure buildout, and manufacturing sector expansion.
The company generates revenue through equipment sales with high initial margins (43.9% gross margin) and recurring aftermarket revenue from spare parts, maintenance contracts, and consumables. Pricing power stems from technical specifications required in regulated industries (pharmaceuticals, food processing) where oil-free air quality is non-negotiable. Operating leverage is strong (34.2% operating margin) due to established distribution network, local manufacturing reducing import duties, and parent company's R&D amortized globally. The installed base of compressors creates annuity-like service revenue with 60-70% gross margins on parts.
India industrial capex cycle and manufacturing PMI - compressor demand correlates directly with factory expansions and production activity
Government infrastructure spending and PLI (Production Linked Incentive) scheme adoption - drives demand from automotive, electronics, and pharmaceutical sectors
Commodity input costs (steel, copper, aluminum) affecting gross margins on equipment sales
Aftermarket service revenue growth rate and installed base expansion - indicates recurring revenue quality and customer retention
Export order momentum to Middle East, Southeast Asia, and Africa markets
Technology shift toward energy-efficient and IoT-enabled compressors - requires continuous R&D investment to maintain competitiveness; newer entrants with digital-first solutions could disrupt traditional equipment sales models
China+1 manufacturing strategy benefiting competitors in Vietnam, Thailand - if India loses manufacturing competitiveness due to infrastructure bottlenecks or policy changes, export demand could weaken
Regulatory changes in environmental standards - stricter energy efficiency mandates could require product redesigns and obsolete existing inventory
Atlas Copco and Kaeser Kompressoren expanding India operations with local manufacturing - could pressure market share in premium segments
Low-cost Chinese manufacturers (Kaishan, Fusheng) gaining share in price-sensitive segments - threatens volume in unregulated industries like textiles and general manufacturing
Vertical integration by large customers (automotive OEMs, steel plants) developing in-house compressed air capabilities for strategic installations
Minimal financial risk given 0.02 D/E ratio and 2.27x current ratio - balance sheet is fortress-like with $2.3B FCF generation
Working capital intensity could increase if payment cycles extend during economic slowdown - currently well-managed but bears monitoring in credit stress scenarios
Foreign exchange exposure on imported components and export receivables - INR depreciation increases input costs while benefiting export competitiveness
high - Compressor sales are directly tied to industrial production, manufacturing capex, and construction activity. During economic expansions, factories invest in new capacity requiring compressed air systems; during downturns, customers defer equipment purchases though aftermarket service remains more resilient. The 11.5% revenue growth reflects India's current industrial expansion phase, but this would contract sharply in recession.
Rising interest rates negatively impact the business through two channels: (1) customer capex decisions become more expensive to finance, potentially delaying large compressor installations, and (2) valuation multiples compress given the stock trades at 31.9x EV/EBITDA. However, the company's own balance sheet is insulated with 0.02 D/E ratio. The 18.6x P/B multiple suggests rate sensitivity primarily affects valuation rather than operations.
Moderate - While the company itself has minimal debt, customer access to credit affects large equipment purchases. Tightening credit conditions in India's banking sector could slow order intake for capital equipment. However, the strong 2.27x current ratio and $2.3B free cash flow provide internal financing flexibility. Pharmaceutical and food processing customers (regulated sectors) typically maintain better credit access than cyclical industries.
growth - The 20.3% EPS growth, 42.2% ROE, and exposure to India's industrialization theme attracts growth investors seeking structural beneficiaries of manufacturing expansion. The 31.9x EV/EBITDA and 18.6x P/B multiples reflect growth premium pricing. Quality-focused investors appreciate the 34.2% operating margin, minimal debt, and strong cash generation ($2.3B FCF). Not a dividend play despite profitability.
moderate-to-high - As a mid-cap industrial stock in emerging markets, expect volatility from: (1) quarterly order lumpiness in capital equipment, (2) INR currency fluctuations, (3) India market sentiment swings, and (4) global industrial cycle concerns. The -0.9% 3-month return versus 11.9% 1-year return illustrates episodic volatility. Beta likely 1.1-1.3x relative to Indian equity indices.